Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 9Unknown 3Terminated 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × VAP-cyclo protocol × Clear all
NCT03631862 2018-08-15

Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

Zhengzhou University

Phase 4 Unknown
100 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03268889 2017-08-31

CHOP

The First Affiliated Hospital of Soochow University

Phase NA Unknown
39 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT01949818 2015-12-30

Treatment of Diffuse Large B Cell Lymphoma

Zhengzhou University

Phase 4 Unknown
120 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡